ClinicalTrialsFinder

Refractory Classic Hodgkin Lymphoma Clinical Trials in Beijing, Beijing Municipality

1 recruitingBeijing, Beijing Municipality, China

Showing 1–1 of 1 trials

Recruiting
Phase 2

Azacitidine Plus PD-1 Therapy for R/R Hodgkin Lymphoma

Refractory Classic Hodgkin LymphomaRelapsed Classic Hodgkin Lymphoma
Navy General Hospital, Beijing40 enrolled1 locationNCT06190067